Merck KGaA (OTCMKTS:MKGAF) Reaches New 12-Month Low – Should You Sell?

Merck KGaA (OTCMKTS:MKGAF) hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $144.39 and last traded at $145.07, with a volume of 4667 shares trading hands. The stock had previously closed at $147.65.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group upgraded Merck KGaA to a “strong-buy” rating in a research note on Thursday, September 19th.

Merck KGaA Stock Performance

The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The firm has a market cap of $18.58 billion, a PE ratio of 21.11 and a beta of 0.96. The business has a 50-day simple moving average of $167.55 and a 200 day simple moving average of $175.39.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.